로타바이러스 백신 시장 보고서 : 동향, 예측 및 경쟁 분석(-2030년)

Rotavirus Vaccine Trends and Forecast

The future of the global rotavirus vaccine market looks promising with opportunities in the hospital and clinic, academic, and research markets. The global rotavirus vaccine market is expected to reach an estimated $17.9 billion by 2030 with a CAGR of 10.1% from 2024 to 2030. The major drivers for this market are augmenting cases and mortality of rotavirus infection and rising awareness about the benefits of rotavirus vaccines among healthcare professionals and parents/caregivers.

A more than 150-page report is developed to help in your business decisions.

Rotavirus Vaccine by Segment

The study includes a forecast for the global rotavirus vaccine by type, end use, and region.

Rotavirus Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Rotarix
• Rotateq
• Rotavin-M1
• Lanzhou Lamb
• Others

Rotavirus Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals and Clinics
• Academic and Research
• Others

Rotavirus Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Rotavirus Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies rotavirus vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the rotavirus vaccine companies profiled in this report include-

• Biovirx
• Serum Institute of India
• Merck & Co
• Bharat Biotech
• Biological E
• Bio Farma
• Novartis
• Glaxosmithkline
• Sanofi
• Lanzhou Institute of Biologicals Products

Rotavirus Vaccine Market Insights

Lucintel forecasts that rotarix is expected to witness highest growth over the forecast period.

APAC is expected to witness highest growth over the forecast period due to growing demand for early detection and treatment of rotavirus infections, rising investment in healthcare infrastructural development, and continuous population growth in the region.

Features of the Global Rotavirus Vaccine Market

Market Size Estimates: Rotavirus vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Rotavirus vaccine market size by type, end use, and region in terms of value ($B).

Regional Analysis: Rotavirus vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the rotavirus vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the rotavirus vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the rotavirus vaccine market size?

Answer: The global rotavirus vaccine market is expected to reach an estimated $17.9 billion by 2030.

Q.2 What is the growth forecast for rotavirus vaccine market?

Answer: The global rotavirus vaccine market is expected to grow with a CAGR of 10.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the rotavirus vaccine market?

Answer: The major drivers for this market are augmenting cases and mortality of rotavirus infection and rising awareness about the benefits of rotavirus vaccines among healthcare professionals and parents/caregivers.

Q4. What are the major segments for rotavirus vaccine market?

Answer: The future of the rotavirus vaccine market looks promising with opportunities in the hospital and clinic, academic, and research markets.

Q5. Who are the key rotavirus vaccine market companies?

Answer: Some of the key rotavirus vaccine companies are as follows:

• Biovirx
• Serum Institute of India
• Merck & Co
• Bharat Biotech
• Biological E
• Bio Farma
• Novartis
• Glaxosmithkline
• Sanofi
• Lanzhou Institute of Biologicals Products

Q6. Which rotavirus vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that rotarix is expected to witness highest growth over the forecast period.

Q7. In rotavirus vaccine market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to growing demand for early detection and treatment of rotavirus infections, rising investment in healthcare infrastructural development, and continuous population growth in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the rotavirus vaccine market by type (rotarix, rotateq, rotavin-m1, lanzhou lamb, and others), end use (hospitals and clinics, academic and research, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Rotavirus Vaccine Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Rotavirus Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Rotavirus Vaccine Market by Type
  • 3.3.1: Rotarix
  • 3.3.2: RotaTeq
  • 3.3.3: Rotavin-M1
  • 3.3.4: Lanzhou lamb
  • 3.3.5: Others
• 3.4: Global Rotavirus Vaccine Market by End Use
  • 3.4.1: Hospitals and Clinics
  • 3.4.2: Academic and Research
  • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Rotavirus Vaccine Market by Region
• 4.2: North American Rotavirus Vaccine Market
  • 4.2.2: North American Rotavirus Vaccine Market by End Use: Hospitals and Clinics, Academic and Research, and Others
• 4.3: European Rotavirus Vaccine Market
  • 4.3.1: European Rotavirus Vaccine Market by Type: Rotarix, RotaTeq, Rotavin-M1, Lanzhou lamb, and Others
  • 4.3.2: European Rotavirus Vaccine Market by End Use: Hospitals and Clinics, Academic and Research, and Others
• 4.4: APAC Rotavirus Vaccine Market
  • 4.4.1: APAC Rotavirus Vaccine Market by Type: Rotarix, RotaTeq, Rotavin-M1, Lanzhou lamb, and Others
  • 4.4.2: APAC Rotavirus Vaccine Market by End Use: Hospitals and Clinics, Academic and Research, and Others
• 4.5: ROW Rotavirus Vaccine Market
  • 4.5.1: ROW Rotavirus Vaccine Market by Type: Rotarix, RotaTeq, Rotavin-M1, Lanzhou lamb, and Others
  • 4.5.2: ROW Rotavirus Vaccine Market by End Use: Hospitals and Clinics, Academic and Research, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Rotavirus Vaccine Market by Type
  • 6.1.2: Growth Opportunities for the Global Rotavirus Vaccine Market by End Use
  • 6.1.3: Growth Opportunities for the Global Rotavirus Vaccine Market by Region
• 6.2: Emerging Trends in the Global Rotavirus Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Rotavirus Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Rotavirus Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: BIOVIRx
• 7.2: Serum Institute of India
• 7.3: Merck & Co
• 7.4: Bharat Biotech
• 7.5: Biological E
• 7.6: Bio Farma
• 7.7: Novartis
• 7.8: GlaxoSmithKline
• 7.9: Sanofi
• 7.10: Lanzhou Institute of Biologicals Products